HIGHLIGHTS
- who: Zoledronic acid, . Breast and George Dranitsaris, Eleftheria Hatzimichael from the Department of Haematology, University of Ioannina, Ioannina, Greece have published the research: Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients, in the Journal: (JOURNAL)
- what: The aim of the trial is to compare the proportion of patients in each group who experience disease recurrence at 5 years. They were applied to the trial results for comparative purposes.
SUMMARY
The concepts are applied to a real . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.